AA
Ashish Anil Vora
About Ashish Anil Vora
Data last updated:
Ashish Anil Vora is a Director at Prime Pharmaceuticals Private Limited (since 1995), Director at Regenix Biosciences Limited (since 2019) and Nominee Director at Odon Prime Pharma Private Limited (since 2024). The companies operate in Pharma, Healthcare and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹790 Cr; the largest is Prime Pharmaceuticals Private Limited at ₹783 Cr (FY 2025). Earlier, Ashish Anil Vora was a Director at Novapri Lifescience Private Limited (2019–2021) and Designated Partner at Smartware It Solution Llp (2014–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Prime Pharmaceuticals Private Limited U24231MH1995PTC092543 | Director | 11 Sep 1995 | 1995 | ₹783 Cr (FY 2025) | Active |
 Regenix Biosciences Limited U24100TN2006PLC059065 | Director | 01 May 2019 | 2006 | ₹6.81 Cr (FY 2025) | Active |
 Odon Prime Pharma Private Limited U21000MH2024PTC424943 | Nominee Director | 09 May 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Novapri Lifescience Private Limited U51909MH2019PTC328092 | Director | 16 Jul 2019 | 2019 | ₹10 Lakh (FY 2025) | Active |
| Smartware It Solution Llp AAC-8400 | Designated Partner | 22 Oct 2014 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ashish Anil Vora
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Anil Vora
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Anil Vora
Ashish Anil Vora currently holds 3 directorships: Prime Pharmaceuticals Private Limited (Director, since 11 Sep 1995, revenue ₹783 Cr (FY 2025)); Regenix Biosciences Limited (Director, since 01 May 2019, revenue ₹6.81 Cr (FY 2025)); Odon Prime Pharma Private Limited (Nominee Director, since 09 May 2024).
Ashish Anil Vora was first appointed on 11 Sep 1995 as Director at Prime Pharmaceuticals Private Limited. The most recent appointment on record is 09 May 2024 at Odon Prime Pharma Private Limited.
The 2 current companies of Ashish Anil Vora that report revenue have a combined latest revenue of ₹790 Cr: Prime Pharmaceuticals Private Limited ₹783 Cr (FY 2025); Regenix Biosciences Limited ₹6.81 Cr (FY 2025).
Ashish Anil Vora held 2 earlier board appointments: Novapri Lifescience Private Limited (Director, 16 Jul 2019 to 09 Nov 2021); Smartware It Solution Llp (Designated Partner, 22 Oct 2014 to 28 Jun 2016).
The current boards of Ashish Anil Vora's companies include Devang Subodh Thakar (Prime Pharmaceuticals Private Limited), Irfan Vazirally (Prime Pharmaceuticals Private Limited), Manish Navnitrai Vora (Prime Pharmaceuticals Private Limited), Manish Patel (Prime Pharmaceuticals Private Limited), Ramamurthy Ayyavuthevar (Prime Pharmaceuticals Private Limited), Balaji Ramamurthy (Regenix Biosciences Limited), among others.